Ironwood Pharmaceuticals (IRWD) Interest & Investment Income (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Interest & Investment Income across 17 years of filings, most recently posting $1.7 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $1.7 million, up 95.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.9 million (up 17.68% YoY), and the FY2025 annual result was $4.1 million, down 8.77% from the prior year.
• Interest & Investment Income came in at $1.7 million for Q1 2026 at Ironwood Pharmaceuticals, up from $1.5 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $8.8 million in Q2 2023 to a low of $230000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $1.2 million (2023), against an average of $2.3 million.
• Across the five-year window, Interest & Investment Income jumped 3061.74% in 2023 and slumped 84.37% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Interest & Investment Income stood at $5.4 million in 2022, then tumbled by 78.08% to $1.2 million in 2023, then tumbled by 34.84% to $778000.0 in 2024, then soared by 87.53% to $1.5 million in 2025, then gained by 16.38% to $1.7 million in 2026.
• The last three Interest & Investment Income figures came in at $1.7 million (Q1 2026), $1.5 million (Q4 2025), and $930000.0 (Q3 2025), per Business Quant data.